Your browser doesn't support javascript.
loading
The effect of hepatitis B virus on the risk of pregnancy outcomes: a systematic review and meta-analysis of cohort studies.
Afraie, Maryam; Moradi, Ghobad; Zamani, Kamran; Azami, Mobin; Moradi, Yousef.
Afiliação
  • Afraie M; Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Moradi G; Department of Epidemiology and Biostatistics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Zamani K; Department of Epidemiology and Biostatistics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Azami M; Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Moradi Y; Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Virol J ; 20(1): 213, 2023 09 14.
Article em En | MEDLINE | ID: mdl-37710321
ABSTRACT

BACKGROUND:

The effect of HBV on neonatal and maternal outcomes can create a basis for more accurate clinical decision-making. So, the aim of this meta-analysis is to detrmine the effect of chronic hepatitis B virus on the risk of pregnancy outcomes by combining cohort studies.

METHODS:

International databases in this meta-analysis included the Cumulated Index to Nursing and Allied Health Literature (CINAHL), SPORT Discuss via the EBSCO interface, PubMed (Medline), Scopus, Web of Science, Embase, which were searched up to April 2023. All cohort studies reporting the risk ratio (RR) with a 95% confidence interval (CI) were included in the study. The quality assessment was done based on the Newcastle-Ottawa Scale (NOS).

RESULTS:

Finally, thirty-five cohort studies were selected for meta-analysis. Outcomes of interest included pre-eclampsia, gestational diabetes, abortion, preterm birth, infant death, and other related outcomes. Results showed that the pooled RR for incident gestational diabetes in pregnant women with choronic hepatitis B infection was 1.16 (RR 1.16; 95% CI 1.13-1.18; I-square 92.89%; P value 0.00). Similarly, the association between the presence of hepatitis B infection in pregnant women and the occurrence of pre-eclampsia was 1.10 (RR 1.10; 95% CI 1.04-1.16; I-square 92.06%; P value 0.00). The risk of preterm delivery in pregnant women with hepatitis B infection was 1.17 times that of pregnant women without hepatitis B infection (RR 1.17; 95% CI 1.14-1.20; I-squared 94.32%; P value 0.00).

CONCLUSION:

This meta-analysis found that hepatitis B infection during pregnancy may be associated with an increased risk of gestational diabetes, preterm delivery, pre-eclampsia, and eclampsia. However, confirmation of this association, as well as the specific biological pathways involved in the association between HBV infection and pregnancy outcomes, requires further investigation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Diabetes Gestacional / Hepatite B Crônica / Nascimento Prematuro / Hepatite B Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Diabetes Gestacional / Hepatite B Crônica / Nascimento Prematuro / Hepatite B Idioma: En Ano de publicação: 2023 Tipo de documento: Article